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ABSTRACT 1 
The aim of this study was to evaluate the physicochemical properties of solid 2 
dispersion on mixtures of hinokitiol (HT) and γ-cyclodextrin (γ-CD) and of HT and 3 
(2-hydroxypropyl)-γ-cyclodextrin (HP-γ-CD). Differential scanning calorimetry 4 
revealed that coground HT/γ-CD at a molar ratio of 1:1 and HT and HP-γ-CD at molar 5 
ratios of 1:1 and 1:2 lacked an endothermic peak due to melting of HT crystals. Powder 6 
x-ray diffraction revealed that HT crystal showed a halo pattern respectively, by mixing 7 
and grinding of the CDs and HT. Thus, coground HT/γ-CD and HT/HP-γ-CD at a molar 8 
ratio of 1:1 had molecular interaction. Assessment of dissolution revealed that ground 9 
mixtures had improved dissolution of HT compared to HT crystals, ground HT alone, 10 
and physical mixtures containing HT. 1H-1H NOESY NMR suggested that the 11 
7-membered ring and isopropyl group of HT were located within the cavity of γ-CD and 12 
HP-γ-CD. The antimicrobial tests indicated that ground mixtures exhibited a minimum 13 
inhibitory concentration (MIC) of 20 μg/mL against Bacillus subtilis, 40 μg/mL against 14 
Staphylococcus aureus, and 20 μg/mL against Escherichia coli. GMs were found to 15 
have 4 times more antimicrobial activity than HT crystals. Ground mixtures also 16 
exhibited MIC of 160 μg/mL against Pseudomonas aeruginosa and they were found to 17 
2 times more antimicrobial activity than HT crystals. Improvement in antimicrobial 18 
activity with the formation of inclusion complexes is presumably due to increase the 19 
solubility of HT as a result of the formation of HT/CD inclusion complexes.  20 
 21 
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Introduction 1 
Hinokitiol (HT) is a crystalline substance with a 7-membered ring structure that is 2 
extracted from the essential oil of certain trees. Since HT is a tropolone derivative, it has 3 
similar anti-bacterial action [1], antifungal action [2, 3], anti-inflammatory action [4], 4 
antioxidant activity [5], melanin inhibition [6] and anti-tumor action [7]. HT has 5 
exceptional biochemical and pharmacological activity. These properties have led to the 6 
use of HT in oral care products in the pharmaceutical field [8, 9]. HT is naturally 7 
occurring and it is known to exhibit exceptional cytotoxic and antimicrobial activity 8 
against oral pathogens and oral squamous epithelial cancer cell lines, so it can be used 9 
safely [10]. Medical use of HT is anticipated to increase in the future. HT is also used as 10 
a preservative in food since it inhibits the enzymatic browning of foods [11]. HT acts by 11 
degrading certain proteins, scavenging free radicals, and chelating metals, so it has been 12 
approved as a food additive and preservative. HT has been used in various fields as 13 
mentioned earlier, and its further use is anticipated in the future. However, HT has poor 14 
solubility since it comes from essential oil. HT is also unstable to light, potentially 15 
resulting in photolysis, polymerization, and condensation and therefore limiting its 16 
effective use. Improved stability to heat, solubility in water, and stability to light are 17 
needed to capitalize on the properties of HT to develop various products. 18 
Cyclodextrin (CD) is, based on the number of glucopyranose units it contains, 19 
classified into α-, β-, and γ-CD. CD is widely used as a host molecule because of the 20 
inclusion complexes formed by each CD. The area near the inlet of the CD cavity is 21 
hydrophilic while the inside is hydrophobic. CD is known, as a result of hydrophobic 22 
interaction in an aqueous solution, to accept various hydrophobic guest molecules into 23 
its cavity to form inclusion complexes [12]. The physical and chemical properties of the 24 
guest molecule are affected by inclusion, i.e. its solubility is improved [13], its stability 25 
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is improved [14], is antibacterial activity is improved [15], its bioavailability is better 1 
controlled [16, 17] and its taste is improved [18]. CDs have been utilized in various 2 
fields, including pharmaceuticals and foods. As an example, α-lipoic acid is a coenzyme 3 
involved in energy production that is present in mitochondria. However, α-lipoic acid is  4 
sensitive to physical changes, light, and heat. The inclusion complex was prepared using 5 
α- lipoic acid and α-CD, β-CD and γ-CD inclusion style different results in type of CD 6 
is obtained. When α-lipoic acid forms inclusion complexes with γ-CD, though, it is 7 
reported to have improved stability against heat, light, and pH changes [19]. Since the 8 
type of guest molecule is determined by it having a size and shape that fits in the CD 9 
cavity, CDs allow the stereoselective formation of inclusion complexes. Therefore, the 10 
form of inclusion is known to differ depending on the type of CD, even when using the 11 
same guest molecule [20]. When candesartan cilexetil is used as a guest molecule, 12 
complex formation is affected by steric hindrance since the size of the CD cavity 13 
depends on the type of CD [21]. 14 
Antimicrobial agents must be effective in small amounts, long-lasting, safe, and easy 15 
to handle. Therefore, natural antimicrobial agents reduce the impact on the environment 16 
and on the human body. This study coground HT to allow its use as a natural 17 
antimicrobial component to form HT/CD inclusion complexes in order to evaluate the 18 
physicochemical properties of HT and study its dissolution. Furthermore, this study 19 
examined the effect that inclusion complex formation had on the antimicrobial activity 20 
of HT.  21 
 22 
Materials and methods 23 
Materials 24 
  HT was a bulk powder manufactured by Wako Pure Chemical Industries Co. Ltd. 25 
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γ-CD was donated by Cyclo Chem Co. Ltd (Tokyo, Japan).  γ-CD was used after 1 
storage at 40°C, 82% RH for 7 days. (2-hydroxypropyl)-γ-cyclodextrin (HP-γ-CD) was 2 
a bulk powder manufactured by Sigma-ALDRICH Co. Ltd. (Tokyo, Japan). HP-γ-CD 3 
was used 0.6 substitutions. All other chemicals and solvents were of analytical grade. 4 
 5 
Preparation of physical mixtures and ground mixtures 6 
 Physical mixtures (PMs) were prepared by mixing γ-CD or HP-γ-CD with HT at 7 
different molar ratios (HT:γ-CD=2:1, 1:1, and 1:2) for 1 minute using a vortex mixer. 8 
Ground mixtures (GMs) were prepared by grinding PMs (1.0 g) for 60 min using a 9 
vibrating rod mill (TI-500ET, CMT Co.) with an aluminum pan.  10 
 11 
Physicochemical characterization 12 
Differential scanning calorimetry (DSC) 13 
 Thermal behavior of samples was recorded using a differential scanning calorimeter 14 
(Thermo plus Evo, Rigaku). All samples were weighed (2 mg) and heated at a 15 
scanning rate of 5.0°C/min with a nitrogen flow rate of 60 mL/min between 30 and 16 
100°C.  Aluminum pans and lids were used for all samples. 17 
 18 
Powder x-ray diffraction  19 
 Powder x-ray diffraction (PXRD) was performed with a powder x-ray 20 
diffractometer (MiniFlex II, Rigaku) using Cu Kα1 radiation, a voltage of 30 KV, and a 21 
current of 15 mA.  Sample powders were placed in glass sample holders.  Samples 22 
were scanned from 3° to 35° (2θ) at a rate 4°/min.   23 
 24 
Fourier transform infrared spectroscopy 25 
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 Fourier transform infrared (FT-IR) absorption spectra of samples were recorded 1 
with a spectrometer (FT/IR-410, JASCO) using the potassium bromide (KBr) disk 2 
method.  Scanning was performed 16 times over a range of 650-4000 cm-1 with a 3 
resolution of 4 cm-1. Tablets were prepared by adding KBr to the sample (ratio of 4 
sample:KBr of 1:10 by weight) and manually compressing the mixture.  5 
 6 
Nuclear magnetic resonance (NMR) measurement using 1H-1H nuclear Overhauser 7 
effect difference spectroscopy (NOESY)  8 
Nuclear magnetic resonance (NMR) spectroscopy was performed using a Varian 9 
NMR System 700 MHz spectrometer (manufactured by Agilent Technologies, Inc.). 10 
Spectroscopy  conditions were a solvent system (D2O:H2O=9:1), a resonant frequency 11 
of 699.6 MHz, a pulse width of 90°, 256 increments, a scan time of 0.500 s, a relaxation 12 
delay of 1.5 s, and a temperature of 25°C. 13 
 14 
Dissolution study 15 
Dissolution testing of samples was performed using a dissolution apparatus 16 
(NTR-593, Toyama Sangyo) at 37±0.5°C with 900 mL of distilled water that was stirred 17 
at 50 rpm using the paddle method. The samples were weighed accurately to be 18 
equivalent to 50 mg of HT. Ten mL of the dissolved sample was collected at 0, 5, 10, 15, 19 
30, and 60 min through 0.45-μm membrane filters. An equal volume of fresh dissolution 20 
medium maintained at the same temperature was added after removing the sample to 21 
keep the volume of dissolution medium constant. Five mL of filtered sample was 22 
diluted to 50 mL with distilled water:methanol (2:8). The concentration of HT in 23 
samples of the diluted solutions was analyzed using UV spectroscopy at 240 nm. 24 
 25 
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Antimicrobial study 1 
The minimum inhibitory concentration (MIC) of HT was measured using agar 2 
dilution procedure. This procedure essentially followed the M7-A7 standard of the 3 
Clinical and Laboratory Standards Institute (CLSI) [22]. Test bacteria used were two 4 
strains of Gram-positive bacteria (Bacillus subtilis NBRC3134 and Staphylococcus 5 
aureus JCM2413) and two strains of Gram-negative bacteria (Escherichia coli 6 
JCM5491 and Pseudomonas aeruginosa JCM6119). Mueller-Hinton II agar (MHA, 7 
Becton, Dickinson and Company, NJ) was used as a test medium. HT was added to have 8 
an concentration of 320 μg/mL in MHA. The mixture was stirred, then sequentially 9 
diluted with MHA to make a serial two-fold dilution. The test plates were prepared and 10 
an inoculum (5-μL) of the bacterium adjusted to 2.0 × 10⁶CFU/mL, was spotted onto a 11 
test plate. After test plates were incubated for 24 hours at 37 °C, the growth of each 12 
strain was observed to determine the MIC [23]. 13 
 14 
Results and Discussion  15 
DSC 16 
 Changes in thermal behavior are reported to appear as a result of the formation of 17 
inclusion complexes [24]. Thus, DSC was performed to examine the thermal behavior 18 
of GMs (Fig. 2, 3). HT crystals and ground HT alone were found to produce an 19 
endothermic peak at around 53°C due to the melting point of HT (Fig. 2a, b). An 20 
HT/γ-CD PM (HT:γ-CD=1:1), an HT/HP-γ-CD PM (HT:HP-γ-CD=1:1), an HT/γ-CD 21 
GM (ground for 60 min, HT:γ-CD=2:1), and an HT/HP-γ-CD GM (ground for 60 min, 22 
HT:HP-γ-CD=2:1) all produced an endothermic peak at around 53°C due to the melting 23 
of HT crystals (Fig. 2e, f. Fig.3e, f). However, HT/γ-CD GMs (ground for 60 min, 24 
HT:γ-CD=1:1 and 1:2) and HT/HP-γ-CD GMs (ground for 60 min, HT:HP-γ-CD=1:1 25 
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and 1:2) did not produce an endothermic peak due to the melting of HT crystals (Fig. 2g, 1 
h. Fig.3g, h).  2 
The aforementioned changes in thermal behavior presumably indicate molecular 3 
interaction in HT/γ-CD, HT/HP-γ-CD, and the GMs. In addition, cogrinding 4 
presumably resulted in molecular interaction of HT and γ-CD at a molar ratio of 1:1.  5 
 6 
PXRD 7 
PXRD was performed to examine the crystalline state of HT/γ-CD, HT/HP-γ-CD, 8 
and coground mixtures of the two. HT crystals and ground HT alone produced a peak 9 
characteristic of HT at 2θ=10.3° and 23.7° (Fig. 4a, b). An HT/γ-CD PM 10 
(HT:γ-CD=1:1) and an HT/HP-γ-CD PM (HT:HP-γ-CD=1:1) produced a diffraction 11 
peak due to HT crystals at 2θ=10.1° and 23.6° and a diffraction peak due to γ-CD at 12 
2θ=12.2° and 16.2° (Fig. 4g, h). In contrast, an HT/γ-CD GM (ground for 60 min, 13 
HT:γ-CD=1:1) and an HT/HP-γ-CD GM (ground for 60 min, HT:HP-γ-CD=1:1) did not 14 
produce a diffraction peak due to HT crystals and or a diffraction peak due to γ-CD or 15 
HP-γ-CD, but they did produce a halo pattern (Fig. 4i, j). Amorphous state, has been 16 
reported that there is a possibility of some interaction is occurring [25].  17 
 18 
FT-IR analysis 19 
 PXRD and DSC presumably indicated molecular interaction of HT and γ-CD or HT 20 
and HP-γ-CD. Thus, FT-IR spectroscopy was performed to examine molecules in a 21 
solid state (Fig. 5). FT-IR spectroscopy revealed that HT crystals produced peaks 22 
presumably due to the carbonyl group (producing a peak at around 1608 cm-1) and the 23 
hydroxyl group (producing a peak at around 3200 cm-1) within the HT molecule (Fig. 24 
5a). An HT/γ-CD PM (HT:γ-CD=1:1) and an HT/HP-γ-CD PM (HT:HP-γ-CD=1:1) 25 
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both produced absorption peaks due to the carbonyl group and hydroxyl group within 1 
the HT molecule as were similarly noted with HT crystals (Fig. 5c, e). However, an 2 
HT/γ-CD GM (ground for 60 min, HT:γ-CD=1:1) caused a lower absorption peak (at 3 
around 1608 cm-1) due to the carbonyl group of HT. An HT/γ-CD GM (ground for 60 4 
min, HT:γ-CD=1:1) and an HT/HP-γ-CD GM (ground for 60 min, HT:HP-γ-CD=1:1) 5 
caused the peak due to the hydroxyl group (at around 3200cm-1) to disappear or they 6 
caused a higher absorption peak (Fig. 5d, f). CD is known to take up a water molecule 7 
when it does not include a guest molecule, and it replaces the water molecule with the 8 
guest molecule as the latter approaches [26]. This probably results in a stable energy 9 
state. A peak due to the water of crystallization present in the 8-membered ring of γ-CD 10 
was noted at around 1653 cm-1. This peak disappeared with an HT/γ-CD GM (ground 11 
for 60 min, HT:γ-CD=1:1) and an HT/HP-γ-CD GM (ground for 60 min, 12 
HT:HP-γ-CD=1:1). Thus, dehydration of the water in CD crystals [27] presumably 13 
produced hydrophobic molecular interaction.  14 
 15 
Dissolution study 16 
 Assessment of the physical properties of compounds in a solid state suggested that 17 
HT/γ-CD and HT/HP-γ-CD had molecular interaction as a result of the cogrinding of 18 
HT and CD. A dissolution test was performed with HT crystals, HT ground for 60 min, 19 
an HT/γ-CD PM (HT:γ-CD=1:1), an HT/HP-γ-CD PM (HT:HP-γ-CD=1:1), an 20 
HT/γ-CD GM (ground for 60 min, HT:γ-CD=1:1), and an HT/HP-γ-CD GM (ground for 21 
60 min, HT:HP-γ-CD=1:1) to determine the solubility of HT as a result of molecular 22 
interaction. Results indicated that HT was present as crystals in the HT-HP-γ-CD PM 23 
(HT:HP-γ-CD=1:1) and in the HT/γ-CD PM (HT:γ-CD=1:1), resulting in limited 24 
contact and slow dissolution. In contrast, an HT/HP-γ-CD GM (ground for 60 min, 25 
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HT:HP-γ-CD=1:1) had a dissolution rate of around 90% and an HT/γ-CD GM (ground 1 
for 60 min, HT:γ-CD=1:1) had a dissolution rate of around 80% at 5 min. In the initial 2 
stages, HT was almost completely dissolved. In the initial stages, HT crystals dissolve 3 
little, and a dissolution rate of around 30% was noted at 60 min. This indicates that an 4 
HT/γ-CD GM (ground for 60 min, HT:γ-CD=1:1) and an HT/HP-γ-CD GM (ground for 5 
60 min, HT:HP-γ-CD=1:1) had improved dissolution of HT compared to HT crystals 6 
(Fig. 6).  7 
In GMs, the formation of inclusion complexes is affected by HT and CD in a solid 8 
state. GMs presumably had improved dissolution compared to HT crystals and PMs.  9 
 10 
1H-1H NOESY NMR 11 
Results of a dissolution test revealed that GMs had improved dissolution compared to 12 
HT crystals alone. Molecular interaction between HT and γ-CD or between HT and 13 
HP-γ-CD in solution may affect solubility. Thus, 1H-1H NOESY NMR spectroscopy 14 
was performed to assess the state of molecules in an aqueous solution.  15 
An HT/γ-CD GM (ground for 60 min, HT:γ-CD=1:1) produced cross-peaks between 16 
the peaks at H-A, B, C, and D due to the 7-membered ring of HT and the peaks at H-3 17 
and H-5 due to γ-CD, and an HT/γ-CD GM (ground for 60 min, HT:γ-CD=1:1) also 18 
produced cross-peaks between the peak at H-F due to the isopropyl group of HT and the 19 
peaks at H-3 and H-5 due to γ-CD (Fig. 7a, b). Similarly, an HT/HP-γ-CD GM (ground 20 
for 60 min, HT:HP-γ-CD=1:1) produced cross-peaks between the peaks at H-A, B, C, 21 
and D due to the 7-membered ring structure of HT and the peaks at H-3, 5 and 6 due to 22 
γ-CD. An HT-HP-γ-CD GM (ground for 60 min, HT:HP-γ-CD=1:1) also produced 23 
cross-peaks between the peak at H-F due to the isopropyl group of HT and the peak at 24 
H-3 due to HP-γ-CD (Fig. 8c, d).  25 
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These findings suggest that HT in a GM of HT/γ-CD enters the γ-CD cavity and that 1 
the 7-membered ring of HT is located near the wider edge of γ-CD. Protons of the 2 
isopropyl group of HT enter the CD cavity and are located near the narrower edge of 3 
CD. In a HT/HP-γ-CD GM, the 7-membered ring of HT enters the CD cavity and is 4 
located near the narrower edge of γ-CD. Protons of the isopropyl group of HT enter the 5 
CD cavity and are located near the wider edge of CD. In HT/γ-CD inclusion complexes, 6 
the isopropyl group of HT enters the CD cavity from its wider edge and the 7 
7-membered ring of HT is located at the narrowed edge. In HT/HP-γ-CD inclusion 8 
complexes, the 7-membered ring of HT enters the CD cavity and the isopropyl group of 9 
HT is located at its wider edge.  These findings suggest that HT/γ-CD and 10 
HT/HP-γ-CD have different forms of inclusion.  11 
 12 
Antimicrobial study 13 
 Inclusion complexes were found to have improved dissolution of HT. Thus, an 14 
antimicrobial test was performed with 4 strains of bacteria to determine whether 15 
inclusion complex formation affects the antimicrobial activity of HT. MICs were also 16 
calculated (Table 1).  17 
 HT crystals exhibited a MIC of 80 μg/mL against B. subtilis, 160 μg/mL against S. 18 
aureus, 80 μg/mL against E. coli, and 320 μg/mL against P. aeruginosa. Ground HT 19 
alone exhibited almost the same MIC as HT crystals exhibited. An HT/γ-CD PM 20 
(HT:γ-CD=1:1) and an HT/HP-γ-CD PM (HT:HP-γ-CD=1:1) were not found to have 21 
improved antimicrobial activity compared to HT crystals. However, an HT/γ-CD GM 22 
(ground for 60 min, HT:γ-CD=1:1) and an HT/HP-γ-CD GM (ground for 60 min, 23 
HT:HP-γ-CD=1:1) exhibited a MIC of 20 μg/mL against B. subtilis, 40 μg/mL against S. 24 
aureus, and 20 μg/mL against E. coli. These GMs were found to have 4 times more 25 
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antimicrobial activity than HT crystals. In addition, an HT/γ-CD GM (ground for 60 1 
min, HT:γ-CD=1:1) and an HT/HP-γ-CD GM (ground for 60 min, HT:HP-γ-CD=1:1) 2 
exhibited a MIC of 160 μg/mL against P. aeruginosa. These GMs were found to have 2 3 
times more antimicrobial activity than HT crystals. The mechanism for the 4 
antimicrobial and microbicidal action of HT is known to be via metabolic inhibition of 5 
the cell membrane in conjunction with reduced permeability of the cell membrane and 6 
suppressed respiration [28]. A study involving the formation of inclusion complexes by 7 
cefdinir, an antibiotic, and HP-β-CD, an analog of β-CD, reported that those complexes 8 
improved the antimicrobial activity of cefdinir against 2 species of bacteria, S. aureus 9 
and E. coli [27]. Formation of inclusion complexes with CD improved the antimicrobial 10 
activity of cefdinir by enhancing its solubility (normally, it is poorly soluble) and 11 
improving its stability.  In the current study, the antimicrobial activity of HT improved 12 
with the formation of inclusion complexes. This is presumably evidence of the 13 
improved solubility of HT. A study reported that inclusion of chlorogenic acid in β-CD 14 
improved the stability of chlorogenic acid and helped to improve its antimicrobial 15 
activity without diminishing its antimicrobial activity [29].  Similarly, inclusion of HT 16 
in CD in the current study improved the stability of HT and may have helped to improve 17 
its antimicrobial activity. The stability of HT and inclusion complexes must be assessed 18 
in the future.  19 
 20 
Conclusion 21 
Use of cogrinding was found to produce HT/γ-CD and HT/HP-γ-CD inclusion 22 
complexes in a solid state. Assessment of the physical properties of the compounds in a 23 
solid state and in solution revealed that the molar ratios for the inclusion complexes 24 
were HT:γ-CD=1:1 and HT:HP-γ-CD=1:1.  25 
13 
 
 Improved solubility of HT was noted with GMs.  The mechanism for this action was 1 
molecular interaction in a solid state and in solution.  2 
Moreover, improved solubility of HT resulted in improved antimicrobial activity of 3 
HT for GMs. CD is reported to form inclusion complexes with other drugs, resulting in 4 
improved stability to light [30]. Similarly, HT formed inclusion complexes with CD in 5 
the current study, inhibiting photolysis. If a high level of antimicrobial activity can be 6 
maintained, then HT can be used to develop products such as food additives and 7 
pharmaceuticals. In addition, this approach may allow effective use of HT in humans 8 
and in the environment.  9 
 In the future, sites of molecular interaction must be elucidated in further detail. 10 
Complexes formed HT by different CDs must also be examined and compared using 11 
various CDs and CD analogs. Moreover, methods of preparation besides cogrinding 12 
must also be studied.  13 
 14 
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Fig. 1 Chemical Structures of (a) HT and (b) γ-CD and HP-γ-CD 13 
 14 
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Table 1  Antimicrobial activity of hinokitiol, PMs and GMs
B. sub : Bacillus subtilis
S. a : Staphylococcus aureus
E. coli : Escherichia coli
P. aer : Pseudomonas aeruginosa
B.sub S.a E.coli P.aer
γ-CD - - - -
HP-γ-CD - - - -
HT crystal 80 160 80 320
HT ground 40 40 80 320
PM (HT:γ-CD=1:1) 40 80 80 320
PM (HT:HP-γ-CD=1:1) 40 80 80 320
GM (HT:γ-CD=1:1) 20 40 20 160
GM (HT:HP-γ-CD=1:1) 20 40 20 160
MIC (μg/mL)
OOH
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Fig. 6 Dissolution profiles of HT/CDs systems in 900 mL of water (37±0.5ºC) 
◇:HT crystal, ◆:HT ground 60min, ○:PM (HT:γ-CD=1:1), □:PM (HT:HP-γ-CD=1:1), ●:GM60min (HT:γ-CD=1:1), 
■:GM60min (HT:HP-γ-CD=1:1).
Results were expressed as mean±S.D. (n=3)
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Fig. 7 1H-1H NOESY NMR spectrum of HT/CDs in D2O
(a) GM60min (molar ratio of HT:γ-CD = 1:1 ) X is 7.0-7.5 and the Y axis is 3.2-4.0,
(b) GM60min (molar ratio of HT:γ-CD = 1:1 ) X is 0.8-1.5 and the Y axis is 3.2-4.0
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Fig. 8 1H-1H NOESY NMR spectrum of HT/CDs in D2O
(c) GM60min (molar ratio of HT:HP-γ-CD = 1:1 ) X is 6.9-7.5 and the Y axis is 3.3-4.0, 
(d) GM60min (molar ratio of HT:HP-γ-CD = 1:1 ) X is 3.3-4.0 and the Y axis is 3.3-4.0
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